Find policies, billing codes, payers, states, and providers
CPT 59025: Fetal Heart Rate Response to Fetal Movement
CPT code 59025 denotes a fetal assessment that measures the fetal heart rate in response to the fetus’s own movements. This clinical test is used to assess fetal well-being during pregnancy and can identify patterns indicative of fetal distress or stability. Nationally, accurate coding and coverage of this service affect prenatal care workflows, utilization tracking, and maternal–fetal health monitoring across payers.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical purpose of the code, typical sites of service, commonly associated diagnostic scenarios, and how this procedure relates to related ultrasound and fetal monitoring services. The publication summarizes payer coverage considerations, common billing modifiers, and associated clinician taxonomies relevant to obstetrics and gynecology.
This summary provides clinicians, billing professionals, and policy stakeholders with a clear reference for the clinical context of 59025, the payment landscape among major national payers, and pointers to related services used in prenatal surveillance.
Customize your policy alerts
Sign up for cpt 59025 policy alerts
Get alerted when payer policies referencing 59025 are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 59025 describes a fetal assessment procedure in which the provider measures the fetal heart rate response to the fetus's own movements. This service evaluates fetal well-being by observing accelerations or decelerations in heart rate correlated with fetal activity.
-
Service type: Antepartum fetal heart rate monitoring (non-stress test / fetal movement response assessment)
-
Typical site of service: Outpatient obstetrics clinic, maternal-fetal medicine unit, or hospital outpatient department where fetal monitoring can be performed and interpreted
National Reimbursement Benchmarks
Medicare’s national mean of $34.4 sits well below BUCA’s average commercial mean of $159.1 for CPT 59025, illustrating a substantial gap between federal payment levels and that commercial benchmark. The separation suggests Medicare reimbursement is roughly $124.7 lower than BUCA’s mean, placing Medicare toward the lower end of the overall national spectrum while BUCA aligns with higher commercial payment tiers.
Dispersion measured by the interquartile spread (P75 minus P25) varies notably across payers. Blue Cross Blue Shield shows one of the widest IQRs at $61.1, indicating greater variability among commercial contracts, while Cigna’s IQR is $39.9 and UnitedHealth Group’s is $35.9. Aetna’s IQR of $55.9 is also relatively wide. BUCA’s IQR is $53.6, and Medicare’s IQR is $26, the tightest of the group, reflecting more consistent locality-based Medicare payments.